Skip to content

Research at St Andrews

Hsa-miR-375 Is Differentially Expressed During Breast Lobular Neoplasia And Promotes Loss Of Mammary Acinar Polarity

Research output: Contribution to journalArticle

DOI

Author(s)

Orsi Giricz, Paul Andrew Reynolds, Andrew Ramnauth, Christina Liu, Tao Wang, Lesley Stead, Geoffrey Childs, Thomas Rohan, Nella Shapiro, Susan Fineberg, Paraic Kenny, Olivier Loudig

School/Research organisations

Abstract

Invasive lobular carcinoma (ILC) of the breast, characterized by loss of E-cadherin expression, accounts for 5–15% of invasive breast cancers and it is believed to arise via a linear histological progression. Genomic studies have identified a clonal relationship between ILC and concurrent lobular carcinoma in situ (LCIS) lesions, suggesting that LCIS may be a precursor lesion. It has been shown that an LCIS diagnosis confers a 15–20% risk of progression to ILC over a lifetime. Currently no molecular test or markers can identify LCIS lesions likely to progress to ILC. Since microRNA (miRNA) expression changes have been detected in a number of other cancer types, we explored whether their dysregulation might be detected during progression from LCIS to ILC. Using the Illumina miRNA profiling platform, designed for simultaneous analysis of 470 mature miRNAs, we analysed the profiles of archived normal breast epithelium, LCIS lesions found alone, LCIS lesions concurrent with ILC, and the concurrent ILCs as a model of linear histological progression towards ILC. We identified two sets of differentially expressed miRNAs, the first set highly expressed in normal epithelium, including hsa-miR-224, -139, -10b, -450, 140, and -365, and the second set up-regulated during lobular neoplasia progression, including hsa-miR-375, -203, -425-5p, -183, -565, and -182. Using quantitative RT-PCR, we validated a trend of increasing expression for hsa-miR-375, hsa-miR-182, and hsa-miR-183 correlating with ILC progression. As we detected increased expression of hsa-miR-375 in LCIS lesions synchronous with ILC, we sought to determine whether hsa-miR-375 might induce phenotypes reminiscent of lobular neoplasia by expressing it in the MCF-10A 3D culture model of mammary acinar morphogenesis. Increased expression of hsa-miR-375 resulted in loss of cellular organization and acquisition of a hyperplastic phenotype. These data suggest that dysregulated miRNA expression contributes to lobular neoplastic progression. Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Close

Details

Original languageEnglish
Pages (from-to)108-119
Number of pages12
JournalJournal of Pathology
Volume226
Issue number1
Early online date26 Sep 2011
DOIs
Publication statusPublished - 1 Jan 2012

    Research areas

  • miR-375, polarity, lobular breast cancer

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031

    Sarr, A., Bré, J., Um, I. H., Chan, T. H., Mullen, P., Harrison, D. J. & Reynolds, P. A., 21 May 2019, In : Scientific Reports. 9, 13 p., 7643.

    Research output: Contribution to journalArticle

  2. Glutaminase inhibition in renal cell carcinoma therapy

    Raczka, A. M. & Reynolds, P. A., 14 May 2019, In : Cancer Drug Resistance. 2, 9 p.

    Research output: Contribution to journalReview article

  3. Podocyte injury elicits loss and recovery of cellular forces

    Haley, K., Kronenberg, N. M., Liehm, P., Elshani, M., Bell, C., Harrison, D. J., Gather, M. C. & Reynolds, P. A., 27 Jun 2018, In : Science Advances. 4, 6, 9 p., eaap8030.

    Research output: Contribution to journalArticle

  4. Crumbs 3b promotes tight junctions in an ezrin-dependent manner in mammalian cells

    Tilston-Lunel, A. M., Haley, K., Schlecht, N., Wang, Y., Chatterton, A. L. D., Moleirinho, S. L., Watson, A., Hundal, H., Prystowsky, M., Gunn-Moore, F. J. & Reynolds, P. A., Oct 2016, In : Journal of Molecular Cell Biology. 8, 5, p. 439-455

    Research output: Contribution to journalArticle

  5. Willing to be involved in cancer

    Gunn-Moore, F. J., Tilston-Lunel, A. M. & Reynolds, P. A., 18 Jul 2016, In : Genes. 7, 7, 13 p., 37.

    Research output: Contribution to journalReview article

Related by journal

  1. Journal of Pathology (Journal)

    C Simon Herrington (Editor)
    20022008

    Activity: Publication peer-review and editorial work typesEditor of research journal

Related by journal

  1. An ex-vivo tumour model using core Biopsy explants validate carbonic anhydrase IX (CAIX) as a therapeutic target in breast cancer

    Ward, C., Meehan, J., Harrison, D. J., Kunkler, I. H. & Langdon, S. P., Sep 2013, In : Journal of Pathology. 231, p. 24 1 p.

    Research output: Contribution to journalAbstract

  2. Characterisation of phosphorylated checkpoint kinase 1 as a poor prognostic biomarker in serous ovarian cancer

    Francis, K. E., Mullen, P., Um, I., Kay, C., Harrison, D. J. & Langdon, S. P., Sep 2013, In : Journal of Pathology. 231, p. 46 1 p.

    Research output: Contribution to journalAbstract

  3. Combination of HER2-targeted antibodies (Trastuzumab plus Pertuzumab) is effective against HER2 amplified ovarian cancer xenograft models

    Langdon, S. P., Sims, A. H. & Harrison, D. J., Sep 2013, In : Journal of Pathology. 231, p. 25 1 p.

    Research output: Contribution to journalAbstract

  4. Use of reverse phase protein arrays to identify biomarkers of response to PI3K/mTOR inhibitors in ovarian cancer models

    Tashkandi, G., Mullen, P., Goltsov, A., Bown, J. L., Harrison, D. J. & Langdon, S. P., Sep 2013, In : Journal of Pathology. 231, p. 25 1 p.

    Research output: Contribution to journalAbstract

ID: 11594799

Top